Loading...
Loading...
Indian Pharmaceutical Exporter Β· #9 for Isoniazid Β· $850.0K export value Β· DGFT Verified
Maneesh Pharmaceuticals Ltd is the #9 Indian exporter of Isoniazid with $850.0K in export value and 17 verified shipments. Maneesh Pharmaceuticals Ltd holds a 0.4% market share in Isoniazid exports across 7 countries.

| Country | Value | Shipments | Share |
|---|---|---|---|
| SUDAN | $643.1K | 13 | 10.9% |
| PHILIPPINES | $462.4K | 19 | 7.9% |
| KENYA | $428.3K | 15 | 7.3% |
| INDONESIA | $403.7K | 13 | 6.9% |
| AFGHANISTAN | $400.0K | 8 | 6.8% |
| CONGO | $350.0K | 7 | 6.0% |
| NAMBIA | $298.7K | 7 | 5.1% |
| ANGOLA | $264.5K | 9 | 4.5% |
| NETHERLANDS | $233.1K | 20 | 4.0% |
| BURUNDI | $200.0K | 4 | 3.4% |
Maneesh Pharmaceuticals Ltd exports Isoniazid to 41 countries. The largest destination is SUDAN accounting for 10.9% of Maneesh Pharmaceuticals Ltd's Isoniazid shipments, followed by PHILIPPINES (7.9%) and KENYA (7.3%). These destinations reflect Maneesh Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AMBICA INTERNATIONAL CORPORATION | PHILIPPINES | $462.4K | 19 |
| SEKRETARIAT DITJEN PENCEGAHAN DAN P | INDONESIA | $400.0K | 8 |
| UNOCA COMPOUND JALALABAD ROAD KABUL | AFGHANISTAN | $250.0K | 5 |
| COUNTRY OFFICE CO BURUNDI | BURUNDI | $200.0K | 4 |
| FEDERAL MINISTRY OF HEALTH | SUDAN | $200.0K | 4 |
| REPUBLIQUE DU CONGO PROGRAMME DES NATIONS UNIESPOUR LE |
India exported $159.1M worth of Isoniazid through 3,835 shipments from 127 suppliers to 163 countries, serving 829 buyers globally. Maneesh Pharmaceuticals Ltd contributes $850.0K to this total, accounting for 0.4% of India's Isoniazid exports. Maneesh Pharmaceuticals Ltd ships Isoniazid to 41 countries through 68 buyers.
Maneesh Pharmaceuticals Ltd's average Isoniazid shipment value is $50.0K per consignment, based on 17 shipments totaling $850.0K. The largest destination is SUDAN (10.9% of Maneesh Pharmaceuticals Ltd's Isoniazid exports).
Maneesh Pharmaceuticals Ltd ranks #9 among 127 Indian Isoniazid exporters with a 0.4% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($69.5M), LUPIN LIMITED ($38.5M), MACLEODS PHARMACEUTICALS LIMITED ($23.9M). Maneesh Pharmaceuticals Ltd processed 17 shipments to 7 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| RIFAMPICIN 150MG / ISONIAZID 75MG / PYRA | $672.9K | 29 |
| RIFAMPICIN 150MG / ISONIAZID 75MG TABS E | $341.6K | 18 |
| RIFAMPICIN 150MG / ISONIAZID 75MG TABS EACH CARTON OF 24X28 TABS | $293.3K | 8 |
| RIFAMPICIN 150MG / ISONIAZID 75MG TABS EACH CARTON OF 24X28 TABS 5280 CARTONS | $150.0K | 3 |
| RIFAMPICIN 150MG / ISONIAZID 75MG / PYRAZINAMIDE 400MG /ETHAMBUTOL 275MG TABS EACH CARTON OF 24X28 TABS 2690 CARTONS | $150.0K | 3 |
| 6 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG/ISONIAZID 75 MG/PYRAZINAMIDE 400MG/ETHAMBUTOL HCL 275MG TABLETS(25602 CNOS | $150.0K | 3 |
| 12 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG/ ISONIAZID 75 MG TABLETS (25602 CARTONS)NOS | $150.0K | 3 |
| RIFAMPICIN 150MG / ISONIAZID 75MG TABS EACH CARTON OF 24x28 TABS |
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | MYLAN LABORATORIES LIMITED | $3.1M | 72 | 14 | $43.4K |
| 7 | OMNICALS PHARMA PRIVATE LIMITED | $1.4M | 29 | 5 | $50.0K |
| 9 | MANEESH PHARMACEUTICALS LTD β | $850.0K | 17 | 7 | $50.0K |
| 10 | RECIPHARM PHARMASERVICES PRIVATE LIMITED | $847.2K | 24 | 1 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 813 | 21.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 796 | 20.8% |
| DELHI AIR | 393 | 10.2% |
| NHAVA SHEVA SEA (INNSA1) | 324 | 8.4% |
| DELHI AIR CARGO ACC (INDEL4) | 316 | 8.2% |
| JNPT/ NHAVA SHEVA SEA | 185 | 4.8% |
| Bombay Air | 163 | 4.3% |
| JNPT | 163 | 4.3% |
Latest developments and market context
Detailed market intelligence for Isoniazid β including regulatory updates, trade policy changes, and competitive landscape analysis β will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records β the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Maneesh Pharmaceuticals Ltd's Isoniazid exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
| CONGO |
| $200.0K |
| 4 |
| FEDERAL MINISTRY OF HEALTH DIRECTORATE OF INTERNATIONAL HEALTHGRANTS | SUDAN | $200.0K | 4 |
| COSPHARM INV T/A M PLUS PHARMACEUTI | NAMBIA | $196.5K | 4 |
| UNDP SOUTH SUDAN | SUDAN | $193.1K | 4 |
| 5 KAMPALA | KENYA | $179.9K | 4 |
Maneesh Pharmaceuticals Ltd supplies Isoniazid to 68 buyers globally. The largest buyer is AMBICA INTERNATIONAL CORPORATION (PHILIPPINES), followed by SEKRETARIAT DITJEN PENCEGAHAN DAN P (INDONESIA) and UNOCA COMPOUND JALALABAD ROAD KABUL (AFGHANISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| $145.6K |
| 3 |
| PHARMA : RIFAMPICIN 150MG + ISONIAZID 75 | $143.1K | 3 |
| RIFAMPICIN 150MG/ISONIAZID 75MG/PYRAZINA | $106.3K | 3 |
Maneesh Pharmaceuticals Ltd exports 109 distinct Isoniazid formulations including tablets, capsules, syrups, and combination drugs. The top formulation is RIFAMPICIN 150MG / ISONIAZID 75MG / PYRA with 29 shipments worth $672.9K.
| $35.3K |
| 12 | CADILA PHARMACEUTICALS LIMITED | $783.6K | 32 | 12 | $24.5K |
Maneesh Pharmaceuticals Ltd ranks #9 among 127 Indian Isoniazid exporters. Average shipment value of $50.0K compared to the market average of $1.3M. The closest competitors by value are MYLAN LABORATORIES LIMITED and OMNICALS PHARMA PRIVATE LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 163+ countries, 829+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Maneesh Pharmaceuticals Ltd.
Request DemoView Pricing βTrade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Isoniazid. For current shipment-level data, contact TransData Nexus.